Brief: Firebrick Pharma Says AAT Conciliation Meeting 1 Has Been Deferred
29/05/2023 09:16
May 29 (Reuters) - Firebrick Pharma Ltd FRE.AX :
* FIREBRICK PHARMA LTD - AAT CONCILIATION MEETING 1, WHICH
WAS
PREVIOUSLY SCHEDULED FOR 30 MAY, HAS BEEN DEFERRED
* FIREBRICK PHARMA LTD - A NEW DATE IS YET TO BE AGREED
BETWEEN
FIREBRICK, TGA 2 AND AAT
Source text for Eikon: ID:nASX9Qfp59
Further company coverage: FRE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement